What Will It Take to Keep Biotech Growing in Europe, Rainer Westermann?
From MAP - Market Access Podcast · 41:41
Show by Dr. Stefan Walzer
In this episode of MAP – the Market Access Podcast, Dr. Stefan Walzer sits down with Rainer Westermann, Chairman of the Life Sciences Acceleration Alliance (LSAA), to ask whether Europe can remain a globally competitive home for life sciences innovation — and what has to change for new therapies to reach patients.Bringing an investor's lens, Rainer explains why so many promising European companies scale in the US instead: the "valley of death" between great science and a viable business, the shortage of productive growth capital, the absence of a deep, liquid capital market, and the drag of long timelines, fragmented member-state systems, and cost-containment-first thinking. They also unpack the ripple effects of the US Most Favored Nation policy, the patent cliff, and why patients — who are also voters — belong at the center of the debate.Stay connected by subscribing on your favorite podcast platform or listening directly on our website: MAP Podcasts —and if you enjoyed the episode, don't forget to rate it and the podcast!MAP is the first and only bi-weekly market access podcast provided by MArS—and the global #1 podcast in the field of health economics. For more information about MArS Market Access and Pricing Strategy, visit: https://marketaccess4-0.com/#MarketAccess #LifeSciences #Biotech #VentureCapital #PharmaInnovation #HealthcareInvestment #EuropeanUnion #MFN #MarketAccessStrategy #marketaccesspodcast
More episodes of MAP - Market Access Podcast
More episodes
- How Will the EU JCA Reshape National HTA Across Europe, Dr. Oriol Solà-Morales?
- How Can HEOR Teams Build Trust in AI-Generated Models, Haidong Feng?
- Can US GLOBE and GUARD Models Really Lower Drug Prices, Brittany La Couture?
- How Do You Build a High-Performing Team in Pharma, Dr. Maurice Kléber?
- Dr. Mathias Flume - AMNOG will change in 2022, but how?
- Prof. Dr. Wagschal - What can we expect from the upcoming elections in Germany?
- Remo Christen – Early paid access in Switzerland – Switzerland, wonderland??
- Prof. Dr. David Matusiewicz & Dr. Anne Sophie Geier - 1 year DIGAs. Is the "fast track process" for digital health applications successful?
- Bibiane Schulte-Bosse - How to fight well in AMNOG negotiations.
- Prof. Peter Zweifel & Door Vonk - Digital innovation - from theory into practice!
PodSearch is a free, independent podcast search engine. Read about PodSearch, the privacy policy or contact us.